Formulation and Drug Delivery

Prioritizing Formulation Strategies for Temperature-Sensitive Biotherapeutics

September 27, 2024

Solving the challenge of better-stabilized temperature-sensitive biomolecules hinges on innovative formulation strategies.

PCI Pharma Invests More Than $365 Million in New and Existing Facilities in US and EU

September 26, 2024

A new Center of Excellence will be established at PCI Pharma Services’ location in Rockford, Ill., and two sites in Ireland will also benefit from the investment.

Hatch-Waxman Amendments Turn 40

September 25, 2024

FDA’s Darby Kozak provided commentary on the anniversary of the Drug Price Competition and Patent Term Restoration Act of 1984.

EMA Recommends Mpox Vaccine for Adolescents

September 24, 2024

The agency is recommending the extension of the smallpox and mpox vaccine, Imvanex, to adolescents aged 12 to 17.

Formulating Inhaled Medicines

September 24, 2024

Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.

Forging Ahead in Formulation

September 23, 2024

New and existing technologies, as well as a patient-centric focus, are pushing drug formulation into exciting directions.

Phillips Medisize to Acquire Vectura, Expanding Inhalation Drug Delivery Capabilities

September 20, 2024

Vectura’s expertise in the field includes formulation and device development for dry powder inhalers and pressurized metered dose inhalers, among other products and services.

Recipharm Investment Will Enhance Oral Solid Development, GMP Pilot-Scale Suites

September 17, 2024

The company said this new commitment to its facility in Germany goes hand in hand with its recently announced ReciPredict, an initiative intended to streamline the product development cycle.

Molecular Modeling in Formulation Development

September 08, 2024

Insights into molecular behaviors and predictive capabilities are bringing numerous benefits.

Responding to Mpox

September 03, 2024

A coordinated and international response is needed to help control the latest mpox outbreak in Africa.